In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.Biocon's partner firm launches diabetes product in Japan
In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
0 коммент.:
Отправить комментарий